Latest Aarey Drugs & Pharmaceuticals stock price
Aarey Drugs & Pharmaceuticals P/E Ratio
AAREYDRUGS • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
58.25
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
58.25
Current Price
₹67.65
EPS (TTM)
₹1.42
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
49.29
Sector Median
25.71
Sector Rank
#11 of 139
Sector Percentile
7.9%
Key P/E Ratio Insights for Aarey Drugs & Pharmaceuticals
- Stock appears overvalued with PE of 58.25, suggesting caution for new investments
- Trading at premium to sector average PE of 49.29
View the AAREYDRUGS equity price for detailed stock performance.
Related Pages for Aarey Drugs & Pharmaceuticals
Additional stock information and data for AAREYDRUGS
Sector P/E Ratio Comparison
Comparing Aarey Drugs & Pharmaceuticals with other companies in Healthcare sector
Sector Average
49.29
Sector Median
25.71
Lowest P/E
0.97
Highest P/E
993.26
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 3.0 | ₹43 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.87 | ₹1,186 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| Galaxy Medicare | GML | 7.25 | ₹24 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.74 | ₹2,188 | Low |
| Zenith Drugs | ZENITHDRUG | 7.9 | ₹76 | Low |
| Brooks Laboratories | BROOKS | 8.01 | ₹184 | Low |
| Vasundhara Rasayans | VRL | 9.97 | ₹37 | Low |